HCW Biologics Inc.
USD0.88
-0.15 (-14.95%)
CEO
Hing C. Wong
IPO Date
2021-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.07
Prev. Close
$1.03
Day Low
$0.87
Day High
$1.07
52W Low
$0.86
52W High
$44.10
Market Cap
$0.00B
Volume
0.47M
| 113,879 |
| $1.28 |
| 27 May 2026 | GARRETT SCOTT T | director | P-Purchase | Acquired | 177,936 | $1.41 |
| 27 May 2026 | GARRETT SCOTT T | director | P-Purchase | Acquired | 177,936 | $1.28 |
| 27 May 2026 | Byam Rebecca | Chief Financial Officer | P-Purchase | Acquired | 14,235 | $1.41 |
| 27 May 2026 | Byam Rebecca | Chief Financial Officer | P-Purchase | Acquired | 14,235 | $1.28 |
| 20 May 2025 | Wong Hing C | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 8,054 | $7.45 |
| 20 May 2025 | Winer Gary M | director | P-Purchase | Acquired | 1,342 | $7.45 |
| 20 May 2025 | GARRETT SCOTT T | director | P-Purchase | Acquired | 13,423 | $7.45 |
| 9 May 2025 | GARRETT SCOTT T | director | P-Purchase | Acquired | 5,385 | $26.00 |